4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-006616
Director acquired 48,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kunkel Lori Anne Director | 2025-03-03 | Option exercise | +27,666 | $3.75 | $103,748 | 48,166 | D |
| Kunkel Lori Anne Director | 2025-03-03 | Option exercise | +20,500 | $6.33 | $129,765 | 68,666 | D |
| Derivatives | |||||||
| Kunkel Lori Anne Director | 2025-03-03 | Option exercise · Stock Option (right to buy) | −27,666 | 5,534 | D | ||
| Kunkel Lori Anne Director | 2025-03-03 | Option exercise · Stock Option (right to buy) | −20,500 | 0 | D | ||
Loading xslF345X05/form4-03042025_100357.xml…